Results 301 to 310 of about 1,394,357 (370)

Metabolism‐Regulating Nanomedicines for Cancer Therapy

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
This review highlights metabolism‐regulating nanomedicines designed to target glycolytic, lipid, amino acid, and nucleotide pathways in tumors. By incorporating metabolism‐regulating agents into versatile nanocarriers such as liposomes, micelles, dendrimers, and engineered bacteria, these platforms achieve targeted delivery, controlled release ...
Xiao Wu, Shiyi Geng, Jian Yang
wiley   +1 more source

De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. [PDF]

open access: yesCancer Res Commun
Tangudu NK   +18 more
europepmc   +1 more source

STUDIES OF PURINE METABOLISM

open access: yesCold Spring Harbor Symposia on Quantitative Biology, 1948
openaire   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption.

Journal of Medicinal Chemistry, 2022
The curative effect of sorafenib in hepatocellular carcinoma (HCC) is limited and sorafenib resistance remains a major obstacle for HCC. To overcome this obstacle, a new photoactive sorafenib-Ru(II) complex Ru-Sora has been designed. Upon irradiation (λ =
Yidan Lai   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy